NIH Hypertension Guidelines Suggest Newer Agents For Certain Risk Factors
Executive Summary
Hypertensive patients with certain comorbidities should begin therapy with drugs that have demonstrated effectiveness for those conditions, updated clinical guidelines from NIH's National Heart, Lung & Blood Institute states
You may also be interested in...
Industry-Funded Trials Often Use Improper Comparators, JAMA Editorial Says
Industry-sponsored comparative trials are often ineffective at answering clinically relevant questions due to the use of substandard comparators, according to a commentary in the April 12 issue of the Journal of the American Medical Association.
Industry-Funded Trials Often Use Improper Comparators, JAMA Editorial Says
Industry-sponsored comparative trials are often ineffective at answering clinically relevant questions due to the use of substandard comparators, according to a commentary in the April 12 issue of the Journal of the American Medical Association.
Antihypertensive Class Labeling On Trial Outcomes Data To Be Assessed
FDA's Cardiovascular & Renal Drugs Advisory Committee will address the generalizability of clinical outcome trials for antihypertensive drug products at its June 15 meeting